Lipid-based nanoparticles external triggered release strategies in cancer nanomedicine
Abstract Nearly half of humanity will develop cancer in their Lifetime. Current therapies, particularly chemotherapeutic drugs, face significant challenges due to the lack of tissue-specific delivery. For example, less than 0.1% of anticancer drugs administered systemically reach the tumor site, res...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2025-10-01
|
| Collection: | Journal of Nanobiotechnology |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12951-025-03704-4 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|